BGB-11417

A Phase 1b/2, Open-Label, Dose Finding, and Expansion Study of the Bcl-2 Inhibitor BGB-11417 in Patients With Myeloid Malignancies

Arms / Cohorts

Experimental:Parts 1 and 2: AML Cohorts

Accepting patients

Experimental:Parts 1 and 2: MDS Cohorts

Accepting patients

Experimental:Part 3: AML and MDS Cohorts

Accepting patients

Experimental:Part 3: AML and MDS Cohort

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.